Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy

Cancer Letters(2020)10.1016/j.canlet.2020.11.022Source: DataRank Database

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy is a research paper published in Cancer Letters (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.50)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Marta Ruiz ORCID,Leyre Silva ORCID,David Repáraz ORCID,Belén Aparicio,Josune Egea ORCID

Live enrichment

PubMed:33232788 PMC:PMC8006848 OpenAlex:https://openalex.org/W3106919519

Intramural NIH HHS

Grant: ZIA CL002120

NCI NIH HHS

Grant: U01 CA224766

Instituto de Salud Carlos III

FWCI

0.50

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8006848

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006848

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8006848

publisherhttps://api.elsevier.com/content/article/PII:S0304383520306200?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383520306200?httpAccept=text/plain

Fields of Study

Phagocytosis and Immune RegulationImmune Cell Function and InteractionImmunotherapy and Immune ResponsesMedicine

MeSH Terms

Immunogenicity, Vaccinec-Mer Tyrosine KinaseImiquimodAxl Receptor Tyrosine KinaseAdjuvants, ImmunologicAnimalsDendritic CellsFemaleHumansImmunotherapyMaleMelanoma, ExperimentalMice, TransgenicPoly I-CProstatic NeoplasmsProto-Oncogene ProteinsPyrimidinesQuinolinesUp-RegulationGene Expression Regulation, NeoplasticLymphocytes, Tumor-InfiltratingInterleukin-10CD8-Positive T-LymphocytesCancer VaccinesReceptor Protein-Tyrosine KinasesCell Line, TumorMice

Keywords

ImmunogenicityAdjuvantVaccinationImiquimodMedicineImmune systemT cellImmunologyCancer researchCancer vaccineBlockadeCD8ImmunotherapyDownregulation and upregulationPharmacologyReceptorBiologyInternal medicineDendritic cellstherapeutic vaccinationIL-10MerTam Receptors

Sustainable Development Goals

SDG 0: No poverty